KLOW 80MG

Chain: Composite formulation combining four peptides: BPC-157 (15aa), TB-500 (43aa fragment), GHK-Cu (tri-peptide copper complex), and KPV (Lys-Pro-Val).
Research focus: Evaluated for its synergistic regenerative potential—supporting angiogenesis, tissue repair, and inflammation modulation.
Studies: Preclinical data on individual components show improved wound healing, collagen synthesis, and anti-inflammatory action; the combination is explored for enhanced recovery outcomes.
Highlights: Designed for advanced regenerative and dermatologic research models exploring cellular renewal and repair.
Disclaimer: Intended for research purposes only. Not for human or animal consumption.